Mirum Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update

Go back to Mirum Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update
(NASDAQ: MIRM) Delayed: 111.07 +3.30 (3.06%)
Previous Close $107.77    52 Week High
Open $105.48    52 Week Low
Day High $111.36    P/E N/A 
Day Low $105.18    EPS
Volume 1,129,074